Deconstructing Script Abandonment: New Perspectives on Why Patients Don't FillView On Demand
Date: Tuesday, April 14
Time: 1:00 PM EST / 10:00 AM PST
As script abandonment is an issue that can ultimately impact patient outcomes, it is important to understand the full range of clinical, social, and economic reasons for this patient behavior. Claims data only tells you part of the picture of script abandonment, and sometimes leave you with more questions than answers. Who are the patients who never even made it to the pharmacy with their script? At what point in their journey did they drop off and become lost to your brand? Why did the abandonment happen, and what are the typical patient profiles? Zitter Health Insights has developed a unique way to capture this type of information, and will provide you key findings around these questions and many more during the webinar.
Key learning objectives:
- WHO: Identify which patient profiles are most likely to fill and most likely to abandon scripts.
- WHAT: Articulate the clinical, economic and social factors that influence patient fill behavior and medication adherence.
- WHERE/WHEN: Outline when and where along their journey patients decide to not fill their script.
- WHY: Pinpoint the “whys” behind script abandonment behavior.
Pamela Morris, Director, Syndicated Research, Zitter Health Insights
Pamela Morris is Director of Syndicated Research at Zitter Health Insights, a research firm that provides insights to life sciences companies on issues of access within healthcare, including payer access and patient access. Pamela oversees several of Zitter's subscription data services including the Managed Care Message Monitor, and its real-time research into the “whys” behind consumer behavior, Consumer Connect. She also oversees the company's Market Research Panel of thousands of patients and the country's largest panel of payer decision-makers. Pamela holds a Bachelor of Science in Biological Sciences and Applied Economics from Cornell University and is currently completing her MBA.